| Location |
Symbol |
Title |
MIM # |
Disorder |
Comments |
Method |
Mouse |
| 5q11.2-q13.1 |
TAF9, TAF2G, TAFII32 |
TAF9 RNA polymerase II, TATA box-binding protein-associated factor, 32kD |
600822 |
|
|
REa, Psh, A |
|
| 5q11.2-q13.2 |
DHFR |
Dihydrofolate reductase |
126060 |
?Anemia, megaloblastic, due to DHFR deficiency (1) |
5q23 = conflicting localization; to other chrs. with amplification;absence/presence of polymorphism pseudogene DHFRP1 on chr. 18 |
S, REa, H, D |
13(Dhfr) |
| 5q11.2-q13.3 |
CRHBP |
Corticotropin releasing hormone-binding protein |
122559 |
|
|
Psh |
13(Crhbp) |
| 5q12 |
ADAMTS6 |
A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 6 |
605008 |
|
|
REa, REc |
|
| 5q12 |
CCNB1 |
Cyclin B1 |
123836 |
|
|
A, REa |
13(Cycb4) |
| 5q12 |
ERBB2IP, ERBIN |
ERBB2 interacting protein |
606944 |
|
|
R, REc |
|
| 5q12 |
ERCC8, CKN1, CSA |
Excision repair cross-complementing rodent repair deficiency, complementation group 8 |
609412 |
Cockayne syndrome, type A, 216400 (3) |
|
Psh |
|
| 5q12 |
LY64, RP105 |
Lymphocyte antigen-64, radioprotective, 105kD |
602226 |
|
|
A |
13(Ly64) |
| 5q12 |
PART1 |
Prostate androgen-regulated transcript 1 |
604991 |
|
|
R, A |
|
| 5q12 |
PDE4D, DPDE3, STRK1 |
Phosphodiesterase-4D, cAMP-specific (dunce, Drosophila, homolog of, phosphodiesterase-E3) |
600129 |
{Stroke, susceptibility to, 1}, 606799 (3) |
|
REa, A, Fd |
13(Pde4D) |
| 5q12-q13 |
ANKRA2, ANKRA |
Ankyrin repeat-containing protein, family A, member 2 |
605787 |
|
|
R, Psh |
|
| 5q12-q13 |
CMYA5, MYOSPRYN, TRIM76 |
Cardiomyopathy-associated protein 5 |
612193 |
|
|
REc |
13(Cmya5) |
| 5q12-q13 |
FOXD1, FKHL8 |
Forkhead box D1 |
601091 |
|
|
A |
|
| 5q12-q13 |
KIF2 |
Kinesin, heavy chain, 2 |
602591 |
|
|
R |
|
| 5q12-q13 |
MCCC2, MCCB |
3-Methylcrotonyl-CoA carboxylase 2 |
609014 |
3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3) |
|
R |
|
| 5q12-q13 |
PLK2, SNK |
Polo-like kinase 2 |
607023 |
|
|
R |
|
| 5q12-q13 |
PMCHL2 |
Pro-melanin-concentrating hormone-like 2 |
176794 |
|
|
REa, A |
|
| 5q12-q14 |
CSPG2, WGN, WGN1, ERVR |
Chondroitin sulfate proteoglycan-2 (versican) |
118661 |
Wagner syndrome 1, 143200 (3) |
|
REa, A, H, Fd |
13(Cspg2) |
| 5q12-q14 |
EEF1B3 |
Eukaryotic translation elongation factor-1, beta-3 |
600656 |
|
?pseudogene |
Psh, A |
|
| 5q12-q14 |
EJM4 |
Myoclonic epilepsy, juvenile, 4 |
611364 |
Myoclonic epilepsy, juvenile, 4 (2) |
max lod at D5S459 |
Fd |
|
| 5q12.1 |
IPO11, RANBP11, SLRN |
Importin 11 |
610889 |
|
|
REc |
|